PATENT CLAIM ANALYSIS

Application Number: 16060711
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["514", "04400A"]

Abstract:
The present invention provides a novel pharmaceutical composition for treating and/or preventing a cancer comprising, as an active ingredient, a polynucleotide derived from various miRNAs associated with cancer, a combination drug of the pharmaceutical composition and another antitumor agent, and a method for treating or preventing a cancer in a subject having the cancer using the pharmaceutical composition or the combination drug. The present invention relates to a pharmaceutical composition for treating and/or preventing a cancer comprising, as an active ingredient, a polynucleotide comprising the nucleotide sequence as set forth in SEQ ID NO: 1 or 2 (wherein when at least a part of the polynucleotide is DNA, uracil in a region corresponding to the DNA in the nucleotide sequence is replaced with thymine).

Claim (Index 7):
The pharmaceutical composition according to  claim 1 , wherein the cancer is a solid cancer.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 2.02985
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15314859', '15744086', '13389428', '15109879', '14948896']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7957303099911623
- 35 USC 102 Novelty (BERT): 0.5248087393233564
- Combined Prediction Score: 0.7686381529243818
- Mean Citation Score: 314.432416
- Max Citation Score: 325.2554
- Similarity Product: 218.48163264058832

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test